Form 4: Amneal Pharmaceuticals Director Alva Emily Peterson Sells 80,000 Shares
SEC Form 4 Filing
Director Alva Emily Peterson sold 80,000 shares of Amneal Pharmaceuticals (AMRX) on March 5, 2025, at an average price of $8.90 per share.
Summary
- On March 5, 2025, Alva Emily Peterson, a director of Amneal Pharmaceuticals, sold 80,000 shares of Class A Common Stock.
- The sale was executed at a weighted average price of $8.90 per share, with individual transactions ranging from $8.62 to $9.00.
- Following the transaction, Peterson directly owns 170,771 shares of Amneal Pharmaceuticals.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative. A director selling shares can sometimes be interpreted negatively, but without more context, it's difficult to draw strong conclusions. The sale itself is a factual event.
Industry Context
Sales by company directors are routinely scrutinized by investors. The sale could be for personal financial planning or diversification reasons. Without additional context, it's difficult to assess the impact on investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of stock sale transaction. |
| 03/07/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.